Bioluminescence and chemiluminescence in drug screening - PubMed (original) (raw)

Review

. 2003 Nov;377(5):826-33.

doi: 10.1007/s00216-003-2096-6. Epub 2003 Jul 19.

Affiliations

• PMID: 12879192
• DOI: 10.1007/s00216-003-2096-6

Review

Bioluminescence and chemiluminescence in drug screening

Aldo Roda et al. Anal Bioanal Chem. 2003 Nov.

Abstract

Drug screening, that is, the evaluation of the biological activity of candidate drug molecules, is a key step in the drug discovery and development process. In recent years, high-throughput screening assays have become indispensable for early stage drug discovery because of the developments in synthesis technologies, such as combinatorial chemistry and automated synthesis, and the discovery of an increasing number of new pharmacological targets. Bioluminescence and chemiluminescence represent suitable detection techniques for high-throughput screening because they allow rapid and sensitive detection of the analytes and can be applied to small-volume samples. In this paper we report on recent applications of bioluminescence and chemiluminescence in drug screening, both for in vitro and in vivo assays. Particular attention is devoted to the latest and most innovative bioluminescence and chemiluminescence-based technologies for drug screening, such as assays based on genetically modified cells, bioluminescence resonance energy transfer (BRET)-based assays, and in vivo imaging assays using transgenic animals or bioluminescent markers. The possible relevance of bioluminescence and chemiluminescence techniques in the future developments of high-throughput screening technologies is also discussed.

PubMed Disclaimer

Similar articles

• Biotechnological applications of bioluminescence and chemiluminescence.
  Roda A, Pasini P, Mirasoli M, Michelini E, Guardigli M. Roda A, et al. Trends Biotechnol. 2004 Jun;22(6):295-303. doi: 10.1016/j.tibtech.2004.03.011. Trends Biotechnol. 2004. PMID: 15158059 Review.
• A lux-based Staphylococcus aureus bioluminescence screening assay for the detection/identification of antibiotics and prediction of antibiotic mechanisms.
  Yang Z, Cui Q, Zhang M, Li Z, Wang M, Xu H. Yang Z, et al. J Antibiot (Tokyo). 2020 Dec;73(12):828-836. doi: 10.1038/s41429-020-0349-7. Epub 2020 Jul 16. J Antibiot (Tokyo). 2020. PMID: 32678336
• Bioluminescence based in vivo screening technologies.
  Kelkar M, De A. Kelkar M, et al. Curr Opin Pharmacol. 2012 Oct;12(5):592-600. doi: 10.1016/j.coph.2012.07.014. Epub 2012 Sep 3. Curr Opin Pharmacol. 2012. PMID: 22954534 Review.
• Current advances in the use of bioluminescence assays for drug discovery: an update of the last ten years.
  Calabretta MM, Michelini E. Calabretta MM, et al. Expert Opin Drug Discov. 2024 Jan-Jun;19(1):85-95. doi: 10.1080/17460441.2023.2266989. Epub 2024 Jan 8. Expert Opin Drug Discov. 2024. PMID: 37814480 Review.
• Exploiting in vitro and in vivo bioluminescence for the implementation of the three Rs principle (replacement, reduction, and refinement) in drug discovery.
  Michelini E, Cevenini L, Calabretta MM, Calabria D, Roda A. Michelini E, et al. Anal Bioanal Chem. 2014 Sep;406(23):5531-9. doi: 10.1007/s00216-014-7925-2. Epub 2014 Jun 8. Anal Bioanal Chem. 2014. PMID: 24908412

Cited by

• Non-invasive detection of a small number of bioluminescent cancer cells in vivo.
  Kim JB, Urban K, Cochran E, Lee S, Ang A, Rice B, Bata A, Campbell K, Coffee R, Gorodinsky A, Lu Z, Zhou H, Kishimoto TK, Lassota P. Kim JB, et al. PLoS One. 2010 Feb 23;5(2):e9364. doi: 10.1371/journal.pone.0009364. PLoS One. 2010. PMID: 20186331 Free PMC article.
• Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells.
  Pfleger KD, Eidne KA. Pfleger KD, et al. Biochem J. 2005 Feb 1;385(Pt 3):625-37. doi: 10.1042/BJ20041361. Biochem J. 2005. PMID: 15504107 Free PMC article. Review.
• New technologies: bioluminescence resonance energy transfer (BRET) for the detection of real time interactions involving G-protein coupled receptors.
  Pfleger KD, Eidne KA. Pfleger KD, et al. Pituitary. 2003;6(3):141-51. doi: 10.1023/b:pitu.0000011175.41760.5d. Pituitary. 2003. PMID: 14974443 Review.
• A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer.
  Hu K, Clément JF, Abrahamyan L, Strebel K, Bouvier M, Kleiman L, Mouland AJ. Hu K, et al. J Virol Methods. 2005 Sep;128(1-2):93-103. doi: 10.1016/j.jviromet.2005.04.012. J Virol Methods. 2005. PMID: 15951029 Free PMC article.
• Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.
  Primadharsini PP, Nagashima S, Nishiyama T, Takahashi M, Murata K, Okamoto H. Primadharsini PP, et al. J Virol. 2022 Mar 23;96(6):e0190621. doi: 10.1128/jvi.01906-21. Epub 2022 Feb 2. J Virol. 2022. PMID: 35107380 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database